![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PSIVIDA ANNOUNCES COLLABORATION WITH CIRRUS PHARMACEUTICALS
PSIVIDA ANNOUNCES COLLABORATION WITH CIRRUS PHARMACEUTICALS
Global nanotechnology company pSivida Limited (NASDAQ:PSDV, ASX:PSD, Xetra:PSI) today announced that it has signed a contract with US based Cirrus Pharmaceuticals, Inc. to accelerate and expand development of a number of specific drug candidates formulated in BioSilicon(TM)to expand a BioSilicon product pipeline of reformulated drugs. The development contract will have an initial extendable term of one year and provide a dedicated team of scientists from Cirrus Pharmaceuticals.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1047791XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct